Publication | Open Access

Dual NK1 antagonists—serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives

Molecular PharmacologyBenzyloxyphenethyl Piperazine DerivativesPsychoactive DrugPsychiatryMedicinePsychotropic MedicationPsychopharmacologyPharmacological AgentNeuropharmacologyPharmacotherapyDrug TherapyPharmacologyDrug DiscoveryPotential Antidepressants